September 24, 2025 |
Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

With over 30 years of deep-rooted expertise in oncology, we partner with our clients at each pivotal moment in their journey, unlocking value through a connected suite of capabilities. Today, we’re proud to announce that a number of our leaders in Inizio have been featured in Forbes’ Voices of Oncology, a collaboration that reflects our commitment to advancing cancer care.
Launching September 9, the ‘Voice of Innovation Partners’ chapter in Forbes’ ‘Voices of Oncology’ features contributions from:
Accelerating innovation in oncology through collaboration, data & technology
The ‘Voice of Innovation Partners’ chapter explores how innovation partners like Inizio harness advanced data analytics, cutting-edge technology, and cross-sector collaboration to:
The book is a powerful collection of insights from global experts and thought leaders, offering a shared perspective on how we can work better together to shape the future of oncology. Voices of Oncology is an initiative of the Oncology Voice Network (OVN), a new platform built to spark connection, share knowledge, and amplify solutions across pharma, biotech, academia, and patient advocacy.
Pre-order now: Forbes’ Voices of Oncology
Available to pre-order now via Amazon – explore the Voices of Oncology here. If you’re looking for a partner who can turn knowledge into action and accelerate the journey from breakthrough science to real-world impact, learn more about us.
This content was provided by Inizio
Latest Content from Inizio
Overview of spondyloarthritis patient profiles and treatment pathways.
How study design which reflects doctors’ real world choices can optimise results.
Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Published in eyeforpharma July 29 by Rachel Howard
HCPs predict the future of the biologics market
What do you know about chaos theory?
Published in pharmaphorum July 2015 by Julie Denny
Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.
An introduction to the HCV LATAM patient.
Published in eyeforpharma 20 May by Rachel Howard
